You just read:

FDA Approves Brineura™ (cerliponase alfa) for the Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare Pediatric Brain Disorder in Children

News provided by

BioMarin Pharmaceutical Inc.

Apr 27, 2017, 13:28 ET